A role for the stringent response in ciprofloxacin resistance in Pseudomonas aeruginosa

Sci Rep. 2024 Apr 13;14(1):8598. doi: 10.1038/s41598-024-59188-z.

Abstract

Pseudomonas aeruginosa is a major cause of nosocomial infections and the leading cause of chronic lung infections in cystic fibrosis and chronic obstructive pulmonary disease patients. Antibiotic treatment remains challenging because P. aeruginosa is resistant to high concentrations of antibiotics and has a remarkable ability to acquire mutations conferring resistance to multiple groups of antimicrobial agents. Here we report that when P. aeruginosa is plated on ciprofloxacin (cipro) plates, the majority of cipro-resistant (ciproR) colonies observed at and after 48 h of incubation carry mutations in genes related to the Stringent Response (SR). Mutations in one of the major SR components, spoT, were present in approximately 40% of the ciproR isolates. Compared to the wild-type strain, most of these isolates had decreased growth rate, longer lag phase and altered intracellular ppGpp content. Also, 75% of all sequenced mutations were insertions and deletions, with short deletions being the most frequently occurring mutation type. We present evidence that most of the observed mutations are induced on the selective plates in a subpopulation of cells that are not instantly killed by cipro. Our results suggests that the SR may be an important contributor to antibiotic resistance acquisition in P. aeruginosa.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bone Plates
  • Ciprofloxacin* / pharmacology
  • Humans
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa / genetics

Substances

  • Ciprofloxacin
  • Anti-Bacterial Agents